Reviewing Organigram Global (NASDAQ:OGI) & Mobia Medical (NASDAQ:MOBI)

Mobia Medical (NASDAQ:MOBI) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, risk and profitability.

Valuation & Earnings

This table compares Mobia Medical and Organigram Global”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$45.28 million	8.04	-$46.50 million	($20.18)	-0.54
Organigram Global	$309.18 million	0.57	-$17.70 million	$0.46	2.71

Organigram Global has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations for Mobia Medical and Organigram Global, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1	1	5	0	2.57
Organigram Global	1	0	2	0	2.33

Mobia Medical presently has a consensus target price of $20.75, suggesting a potential upside of 89.84%. Given Mobia Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Mobia Medical is more favorable than Organigram Global.

Profitability

This table compares Mobia Medical and Organigram Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Organigram Global	28.14%	-13.39%	-8.67%

Insider and Institutional Ownership

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Organigram Global beats Mobia Medical on 7 of the 13 factors compared between the two stocks.

About Mobia Medical

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

About Organigram Global

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.